MVP ASX · Health Care

Medical Developments International Ltd

Announcements, last 12 months: 27
Price sensitive, last 12 months: 11
Followed on InvestorPA: High (Among the 5% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
29 Oct 2026, 4:32 PM	Change in substantial holding
15 Oct 2026, 9:11 AM	Appendix 4C and Quarterly Activity Report -30 September 2026 Price sensitive	AI summary
15 Oct 2026, 9:09 AM	CEO Transition Price sensitive	AI summary
9 Oct 2026, 9:39 AM	Corporate Governance Statement 2026
9 Oct 2026, 9:39 AM	Notice of Annual General Meeting 2026
9 Oct 2026, 9:39 AM	Annual Report 2026
9 Oct 2026, 9:38 AM	Appendix 4G 2026
29 Sep 2026, 2:45 PM	Notification of cessation of securities - MVP
18 Sep 2026, 9:00 AM	Date of AGM and Closing Date for Director Nominations
20 Aug 2026, 8:56 AM	MVP Announces FY26 Full Year Results Price sensitive	AI summary

Sign in to see all MVP announcements.

Guidance history

20 Aug 2026	Net profit after tax $0.6 million for FY26, Group revenue $42.6 million, Penthrox volume growth 28% Australia, 18% Europe
20 Aug 2026	Higher in-market Penthrox® demand expected in FY27
20 Aug 2026	FY27 revenue expected to be higher due to increased Penthrox demand

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow MVP to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.